RARE Competitors & Alternatives
Compare Ultragenyx with similar stocks in the same industry
Biotechnology
RARE
Main Stock$33.47
Tradestie Score
56
Market Cap
$2.89B
Revenue Growth
0.0%
Analyst Upside
+55.5%
Top Competitors
231 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
TLX
Telix Pharmaceuticals Limited American Depositary Shares
|
$11.87
|
$3.40B | - | 56 | Compare |
|
QURE
uniQure N.V.
|
$41.81
|
$3.39B | - | 61 | Compare |
|
SRRK
Scholar Rock Holding Corporation Common Stock
|
$54.88
|
$3.33B | - | 65 | Compare |
|
NAMS
NewAmsterdam Pharma Company N.V. Ordinary Shares
|
$34.83
|
$3.31B | - | 55 | Compare |
|
SLNO
Soleno Therapeutics, Inc. Common Stock
|
$53.01
|
$3.20B | 27.5 | 49 | Compare |
|
MLYS
Mineralys Therapeutics, Inc. Common Stock
|
$27.69
|
$3.09B | - | 56 | Compare |
|
VKTX
Viking Therapeutics, Inc
|
$37.44
|
$3.08B | - | 63 | Compare |
|
CNTA
Centessa Pharmaceuticals plc American Depositary Shares
|
$40.50
|
$3.03B | - | 61 | Compare |
|
XENE
Xenon Pharmaceuticals Inc
|
$60.96
|
$3.02B | - | 54 | Compare |
|
CGON
CG Oncology, Inc. Common stock
|
$70.36
|
$3.01B | - | 59 | Compare |
More RARE Analysis
Data updated: Jul 04, 2026 | Industry: Biotechnology (SIC 2834)
231 stocks in this industry